Antoni X. Torres‐Collado
- Molecular Biology
- Immunology top 10%
- Oncology top 10%
- Cancer Research top 10%
- Epidemiology
- Co-authors
- M. Luisa Iruela‐ArispeAli R. JazirehiJuan Carlos Rodríguez‐ManzanequeAldons J. LusisSaul J. PricemanJames L. SungDonald A. CohenLily Wu
- Topics
- Protease and Inhibitor Mechanisms (4 papers)CAR-T cell therapy research (3 papers)Melanoma and MAPK Pathways (3 papers)
- Partner nations
- United StatesSpainGermany
In The Last Decade
Antoni X. Torres‐Collado
17 papers receiving 860 citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 376
- Immunology 309
- Oncology 266
- Cancer Research 186
- Epidemiology 84
Countries citing papers authored by Antoni X. Torres‐Collado
This map shows the geographic impact of Antoni X. Torres‐Collado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antoni X. Torres‐Collado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antoni X. Torres‐Collado more than expected).
Fields of papers citing papers by Antoni X. Torres‐Collado
This network shows the impact of papers produced by Antoni X. Torres‐Collado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antoni X. Torres‐Collado. The network helps show where Antoni X. Torres‐Collado may publish in the future.
Co-authorship network of co-authors of Antoni X. Torres‐Collado
This figure shows the co-authorship network connecting the top 25 collaborators of Antoni X. Torres‐Collado. A scholar is included among the top collaborators of Antoni X. Torres‐Collado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antoni X. Torres‐Collado. Antoni X. Torres‐Collado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 38 | |
| 2 | 42 | |
| 3 | 9 | |
| 4 | 137 | |
| 5 | 36 | |
| 6 | Aberrant apoptotic machinery confers melanoma dual resistance to BRAF(V600E) inhibitor and immune effector cells: immunosensitization by a histone deacetylase inhibitor. | 27 |
| 7 | 2 | |
| 8 | Role of miR-18b/MDM2/p53 circuitry in melanoma progression. | 6 |
| 9 | 36 | |
| 10 | Epigenetic regulation of melanoma tumor suppressor miRNA-124a. | 6 |
| 11 | 19 | |
| 12 | 36 | |
| 13 | 60 | |
| 14 | 282 | |
| 15 | 68 | |
| 16 | 50 | |
| 17 | 16 |
About Antoni X. Torres‐Collado
Antoni X. Torres‐Collado is a scholar working on Immunology and Allergy, Cancer Research and Gastroenterology, having authored 17 papers that have together received 870 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (4 papers), CAR-T cell therapy research (3 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Immunology (309 citations), Cancer Research (186 citations) and Immunology and Allergy (72 citations). Antoni X. Torres‐Collado has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include M. Luisa Iruela‐Arispe, Ali R. Jazirehi, Juan Carlos Rodríguez‐Manzaneque, Aldons J. Lusis, Saul J. Priceman, James L. Sung, Donald A. Cohen, Lily Wu, Jeremy B. Burton and Diana Moughon. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.